223 related articles for article (PubMed ID: 21295051)
1. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.
Wilson VS; Keshava N; Hester S; Segal D; Chiu W; Thompson CM; Euling SY
Toxicol Appl Pharmacol; 2013 Sep; 271(3):299-308. PubMed ID: 21295051
[TBL] [Abstract][Full Text] [Related]
2. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
[TBL] [Abstract][Full Text] [Related]
3. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
4. An approach for integrating toxicogenomic data in risk assessment: the dibutyl phthalate case study.
Euling SY; Thompson CM; Chiu WA; Benson R
Toxicol Appl Pharmacol; 2013 Sep; 271(3):324-35. PubMed ID: 23537663
[TBL] [Abstract][Full Text] [Related]
5. Use of genomic data in risk assessment case study: I. Evaluation of the dibutyl phthalate male reproductive development toxicity data set.
Makris SL; Euling SY; Gray LE; Benson R; Foster P
Toxicol Appl Pharmacol; 2013 Sep; 271(3):336-48. PubMed ID: 20849870
[TBL] [Abstract][Full Text] [Related]
6. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
7. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
8. Use of genomic data in risk assessment case study: II. Evaluation of the dibutyl phthalate toxicogenomic data set.
Euling SY; White LD; Kim AS; Sen B; Wilson VS; Keshava C; Keshava N; Hester S; Ovacik MA; Ierapetritou MG; Androulakis IP; Gaido KW
Toxicol Appl Pharmacol; 2013 Sep; 271(3):349-62. PubMed ID: 21745491
[TBL] [Abstract][Full Text] [Related]
9. Toxicogenomics: regulatory perspective on current position.
Battershill JM
Hum Exp Toxicol; 2005 Jan; 24(1):35-40. PubMed ID: 15727054
[TBL] [Abstract][Full Text] [Related]
10. Integrating mechanistic and polymorphism data to characterize human genetic susceptibility for environmental chemical risk assessment in the 21st century.
Mortensen HM; Euling SY
Toxicol Appl Pharmacol; 2013 Sep; 271(3):395-404. PubMed ID: 21291902
[TBL] [Abstract][Full Text] [Related]
11. Clearing the standards landscape: the semantics of terminology and their impact on toxicogenomics.
Burgoon LD
Toxicol Sci; 2007 Oct; 99(2):403-12. PubMed ID: 17483496
[TBL] [Abstract][Full Text] [Related]
12. Pathway analysis tools and toxicogenomics reference databases for risk assessment.
Ganter B; Zidek N; Hewitt PR; Müller D; Vladimirova A
Pharmacogenomics; 2008 Jan; 9(1):35-54. PubMed ID: 18154447
[TBL] [Abstract][Full Text] [Related]
13. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
14. The use of toxicogenomic data in risk assessment: a regulatory perspective.
Chan VS; Theilade MD
Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
[TBL] [Abstract][Full Text] [Related]
15. Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasets.
Scott DJ; Devonshire AS; Adeleye YA; Schutte ME; Rodrigues MR; Wilkes TM; Sacco MG; Gribaldo L; Fabbri M; Coecke S; Whelan M; Skinner N; Bennett A; White A; Foy CA
Toxicology; 2011 Nov; 290(1):50-8. PubMed ID: 21871943
[TBL] [Abstract][Full Text] [Related]
16. How can toxicogenomics inform risk assessment?
Oberemm A; Onyon L; Gundert-Remy U
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):592-8. PubMed ID: 15990130
[TBL] [Abstract][Full Text] [Related]
17. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
[TBL] [Abstract][Full Text] [Related]
18. dbZach: A MIAME-compliant toxicogenomic supportive relational database.
Burgoon LD; Boutros PC; Dere E; Zacharewski TR
Toxicol Sci; 2006 Apr; 90(2):558-68. PubMed ID: 16403854
[TBL] [Abstract][Full Text] [Related]
19. dbZach toxicogenomic information management system.
Burgoon LD; Zacharewski TR
Pharmacogenomics; 2007 Mar; 8(3):287-91. PubMed ID: 17324117
[TBL] [Abstract][Full Text] [Related]
20. Progress and promises in toxicogenomics in aquatic toxicology: is technical innovation driving scientific innovation?
Fent K; Sumpter JP
Aquat Toxicol; 2011 Oct; 105(3-4 Suppl):25-39. PubMed ID: 22099342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
